SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$4.58
0.35 (8.27%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 27, 2026
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBC is fairly valued with market pricing in 0.5% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: SBC is fairly valued with market pricing in 0.5% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.34
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$3.32
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $4.58, which is considered extended relative to its 30-day fair value range of $4.29 to $4.50. The stock's valuation (Forward PE: 8.8) is in line with its historical norms (8.7). At these levels, the market is pricing in 0.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SBC is showing sideways momentum. The price is approaching resistance at $4.52. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.17 (+93.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBC is showing sideways momentum. The price is approaching resistance at $4.52. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.17 (+93.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.29 -
$4.50
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.7%
Protect Your Profits
Holding SBC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.3%)
- BULLISH: Trading 93.1% below Wall St target ($8.17)
- NEUTRAL: Market pricing in 0.5% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$4.29 -
$4.50
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$4.12
Resistance Level
$4.52
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
8.81
Wall Street Target
$8.17
(+93.1%)
Revenue Growth (YoY)
-18.3%
Earnings Growth (YoY)
319.4%
Profit Margin
24.3%
Valuation Premium vs History
+0.5% premium
PE vs Historical
8.8 vs 8.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.5%
(market-implied from PE analysis)
1-Year Target
$4.25
(+1%)
2-Year Target
$4.27
(+1%)
3-Year Target
$4.29
(+2%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$4.24
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 6.1%)
$12.78
(+202%)
Base:
(SPY PE: 8.8, Growth: 6.1%)
$5.05
(+19%)
Bear:
(PE: 7.5, Growth: 6.1%)
$4.29
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 10.00 | Current EPS (TTM): $0.42
Bull Case
$5.28
(+25%)
Analyst growth 14.3%, PE expands to 11.0
Base Case
$4.80
(+14%)
Market implied 14.3%, PE stable at 10.0
Bear Case
$2.86
(-33%)
Severe decline -20.0%, PE contracts to 8.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$263 | 57 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$249 | 60 BUY |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$216 | 51 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$103 | 60 HOLD |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$109 | 51 HOLD |
Advanced SBC Option Strategies
Professional options setups generated by AI based on today's SBC price and gamma walls.
